No data on nuclear HER3 expression exist in breast cancer, but a recent report showed that nuclear HER3 was absent in nonmalignant prostate tissue, whereas it was highly expressed in the cancerous prostate tissue and associated with increased tumor grade [51]. This evidence concerns the gene ERBB3 and breast cancer.